Xenon Pharmaceuticals DPO Ratio 2011-2026 | XENE

Annual DPO Ratio Xenon Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	40.5	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
40.5	40.5	40.5

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Benitec Biopharma BNTC	-556	$ 10.98	-4.52 %	$ 452 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Axsome Therapeutics AXSM	529	$ 156.92	-1.23 %	$ 7.81 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
BioMarin Pharmaceutical BMRN	245	$ 54.13	-1.64 %	$ 10.4 B	USA
Compugen Ltd. CGEN	82.7	$ 2.09	-0.95 %	$ 195 M	Israel
Coherus BioSciences CHRS	507	$ 1.52	-5.59 %	$ 178 M	USA
Clovis Oncology CLVS	236	-	-7.23 %	$ 13 M	USA
Curis CRIS	3.24 K	$ 0.77	1.89 %	$ 4.86 M	USA